tiprankstipranks

BioCryst CEO to serve as interim CFO

In a regulatory filing, BioCryst (BCRX) noted that as previously announced, on February 28, Anthony Doyle, the Chief Financial Officer and Interim Principal Accounting Officer of BioCryst Pharmaceuticals notified the company of his intention to resign from his employment with the company, effective April 9. On April 7, the board appointed Jon Stonehouse, the company’s Chief Executive Officer, to serve as interim Chief Financial Officer and Interim Principal Accounting Officer, the filing stated. The company has also hired a former public biotechnology company Chief Financial Officer as a financial consultant to support Mr. Stonehouse while the company continues its search for a new Chief Financial Officer, the filing noted.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue